GlassScriptPhysician profile
Scott Brandon
NPI 1235735499
$957.05
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $534 · 2022: $324 · 2023: $98.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $124.54 | 2021-2022 | |
| Abbvie INC. | $117.70 | 2021-2022 | |
| Dexcom, INC. | $103.20 | 2021-2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $84.02 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $71.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.96 | 2021 | |
| Janssen Pharmaceuticals, INC | $56.66 | 2021-2022 | |
| Lilly USA, LLC | $56.35 | 2021-2023 | Jardiance |
| Amgen INC. | $51.95 | 2021-2022 | |
| Glaxosmithkline, LLC. | $51.29 | 2021 | |
| Novavax INC | $32.97 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Astrazeneca Pharmaceuticals LP | $29.84 | 2021 | |
| Lundbeck LLC | $28.11 | 2022 | |
| Jazz Pharmaceuticals INC. | $19.96 | 2021 | |
| Renalytix Ai, INC. | $16.80 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.52 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.80 | 2022 | |
| Nabriva Therapeutics, Plc | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Brandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.